arrow
R

Régis Bordet

Université de Lille
H指数:67
被引数:1.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Blood DNA methylomic signatures associated with CSF biomarkers of Alzheimer's disease in the EMIF-AD study

Emif-ad研究中与阿尔茨海默病CSF生物标志物相关的血液DNA甲基组学特征

2024-08-280
OAAI
Strategic white matter hyperintensity locations associated with post-stroke cognitive impairment: A multicenter study in 1568 stroke patients

与卒中后认知障碍相关的战略性白质高强度位置: 1568卒中患者的多中心研究

2024-06-021
OAAI
Statin Therapy for Secondary Prevention in Ischemic Stroke Patients With Cerebral Microbleeds

他汀类药物在缺血性脑卒中伴脑微出血患者二级预防中的应用

2024-04-093
PRE
Network analysis of neuropsychiatric, cognitive, and functional complications of stroke: implications for novel treatment targets
2024-01-290
OA
Clinical Associations and Prognostic Value of MRI-Visible Perivascular Spaces in Patients With Ischemic Stroke or TIA
2024-01-090
OAAI
White Matter Hyperintensity Volume and Poststroke Cognition: An Individual Patient Data Pooled Analysis of 9 Ischemic Stroke Cohort Studies
STROKE
IF8.9
2023-12-017
OAAI
Sex Differences in Poststroke Cognitive Impairment: A Multicenter Study in 2343 Patients With Acute Ischemic Stroke

卒中后认知功能障碍的性别差异: 2343例急性缺血性卒中患者的多中心研究

STROKE
IF8.9
2023-09-0112
OAAI
Short-term Trajectories of Poststroke Cognitive Function A STROKOG Collaboration Study
2023-06-064
PRE
Impact of Cerebral Microbleeds in Stroke Patients with Atrial Fibrillation
2023-04-1711
OA
Stroke Risk and Antithrombotic Treatment During Follow-up of Patients With Ischemic Stroke and Cortical Superficial Siderosis
2023-03-212
OA
Whole-exome rare-variant analysis of Alzheimer's disease and related biomarker traits
2022-12-046
OA
Trial of Deferiprone in Parkinson's Disease

去铁酮在帕金森病中的试验

2022-12-01100
OA